Showing results (781-790 of 834) with videos related to

Sort By:
Pageof 84
Acta Neuropathologica|January 18, 2012
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trialMonika E Hegi, Robert-Charles Janzer, Wanyu L Lambiv, et al.
The Lancet. Oncology|May 4, 2023
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trialAdam M Sonabend, Andrew Gould, Christina Amidei, et al.
Advanced Healthcare Materials|April 23, 2014
Gel scaffolds of BMP-2-binding peptide amphiphile nanofibers for spinal arthrodesisSungsoo S Lee, Erin L Hsu, Marco Mendoza, et al.
Acta Neuropathologica|January 26, 2018
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033Pierre Bady, Sebastian Kurscheid, Mauro Delorenzi, et al.
Nature|August 24, 2012
Room-temperature ferroelectricity in supramolecular networks of charge-transfer complexesAlok S Tayi, Alexander K Shveyd, Andrew C-H Sue, et al.
The New England Journal of Medicine|November 16, 2017
Lomustine and Bevacizumab in Progressive GlioblastomaWolfgang Wick, Thierry Gorlia, Martin Bendszus, et al.
Nature Nanotechnology|June 27, 2017
Sulfated glycopeptide nanostructures for multipotent protein activationSungsoo S Lee, Timmy Fyrner, Feng Chen, et al.
Neuro-Oncology|April 29, 2017
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteriaLakshmi Nayak, Lisa M DeAngelis, Alba A Brandes, et al.
The Journal of Clinical Investigation|February 16, 2026
STING-induced blood-brain barrier opening combined with radiotherapy potentiates antitumor response in a high-grade glioma modelShashwat Tripathi, Hinda Najem, Lisa Hurley, et al.
The Journal of Clinical Investigation|August 13, 2024
Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytomaShashwat Tripathi, Hinda Najem, Corey Dussold, et al.
Pageof 84